Subscribe To
Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors
LEXINGTON, Mass., April 19, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today announced that it appointed Alpna Seth, Ph.D., to its […] The post Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors...
Read More
Posted: Apr 19 2023, 12:00
Author Name: forextv
Views: 082091